FI924088A0 - Anvaendning av prostaglandin f3a som oegontryck saenkande medel. - Google Patents

Anvaendning av prostaglandin f3a som oegontryck saenkande medel.

Info

Publication number
FI924088A0
FI924088A0 FI924088A FI924088A FI924088A0 FI 924088 A0 FI924088 A0 FI 924088A0 FI 924088 A FI924088 A FI 924088A FI 924088 A FI924088 A FI 924088A FI 924088 A0 FI924088 A0 FI 924088A0
Authority
FI
Finland
Prior art keywords
prostaglandin
saenkande
oegontryck
medel
anvaendning
Prior art date
Application number
FI924088A
Other languages
English (en)
Other versions
FI924088A (fi
Inventor
David Frederick Woodward
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of FI924088A publication Critical patent/FI924088A/fi
Publication of FI924088A0 publication Critical patent/FI924088A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Exposure Control For Cameras (AREA)
FI924088A 1990-03-12 1992-09-11 Anvaendning av prostaglandin f3a som oegontryck saenkande medel. FI924088A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/491,546 US5011856A (en) 1990-03-12 1990-03-12 Use of prostaglandin F3 α as an ocular hypotensive agent
PCT/US1991/000988 WO1991013620A1 (en) 1990-03-12 1991-02-12 USE OF PROSTAGLANDIN F3α AS AN OCULAR HYPOTENSIVE AGENT

Publications (2)

Publication Number Publication Date
FI924088A FI924088A (fi) 1992-09-11
FI924088A0 true FI924088A0 (fi) 1992-09-11

Family

ID=23952683

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924088A FI924088A0 (fi) 1990-03-12 1992-09-11 Anvaendning av prostaglandin f3a som oegontryck saenkande medel.

Country Status (11)

Country Link
US (1) US5011856A (fi)
EP (1) EP0527748B1 (fi)
JP (1) JPH05504962A (fi)
AT (1) ATE138574T1 (fi)
CA (1) CA2075951A1 (fi)
DE (1) DE69119900T2 (fi)
ES (1) ES2088489T3 (fi)
FI (1) FI924088A0 (fi)
HU (1) HUT61470A (fi)
IE (1) IE910794A1 (fi)
WO (1) WO1991013620A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270049A (en) * 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055593A (en) * 1971-02-19 1977-10-25 Alza Corporation Alkyl diethers of prostaglandins
US3940438A (en) * 1971-05-24 1976-02-24 Alza Corporation Crystalline racemic 9α,11α,15(S)-trihydroxy-5-cis,13-trans-prostadienoic acid
US3853854A (en) * 1971-06-24 1974-12-10 Alza Corp Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
US3882245A (en) * 1972-11-01 1975-05-06 Upjohn Co Use of prostaglandins in combating shock
US3941886A (en) * 1973-09-21 1976-03-02 Alza Corporation Pharmaceutical compositions containing crystalline racemic 9α, 11α, 15(S)-trihydroxy-5-cis, 13-trans-prostadienoic acid
US4049678A (en) * 1976-03-29 1977-09-20 The Upjohn Company 9-Deoxy-PGD-type, 1,15-lactones
US4033989A (en) * 1975-09-17 1977-07-05 The Upjohn Company 9-Deoxy-PGF2 Analogs
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4201873A (en) * 1975-09-17 1980-05-06 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD2 analogs
US4060540A (en) * 1975-09-18 1977-11-29 American Cyanamid Company Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US4149007A (en) * 1977-06-23 1979-04-10 Miles Laboratories, Inc. C14 Phenyl-substituted derivatives of prostaglandin analogues
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
SE8703854D0 (sv) * 1987-10-07 1987-10-07 Pharmacia Ab Prostaglandinderivat for behandling av glaukom eller okuler hypertension
WO1992010193A2 (en) * 1990-12-10 1992-06-25 Allergan, Inc. Homo-prostaglandin derivatives as ocular hypotensives

Also Published As

Publication number Publication date
DE69119900T2 (de) 1997-02-06
WO1991013620A1 (en) 1991-09-19
US5011856A (en) 1991-04-30
ES2088489T3 (es) 1996-08-16
DE69119900D1 (de) 1996-07-04
IE910794A1 (en) 1991-09-25
EP0527748B1 (en) 1996-05-29
EP0527748A1 (en) 1993-02-24
JPH05504962A (ja) 1993-07-29
EP0527748A4 (en) 1993-03-10
CA2075951A1 (en) 1991-09-13
FI924088A (fi) 1992-09-11
HUT61470A (en) 1993-01-28
ATE138574T1 (de) 1996-06-15

Similar Documents

Publication Publication Date Title
FI924553A (fi) Tiofensulfonamider anvaendbara som kolanhydrasinhibitorer
YU47204B (sh) Derivati didehidro-vitamina d3
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
KR870005637A (ko) 약물 데포
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
SE9503143D0 (sv) New preparation
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
ES2184836T3 (es) Composiciones que contienen derivados de azol para aplicacion topica en la piel.
NO944210L (no) Minimalisering av progestin-forbundet uregelmessig blödning
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
DE69033970T2 (de) Huperzin a analoge verbindungen
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
AR004691A1 (es) Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
FI924088A0 (fi) Anvaendning av prostaglandin f3a som oegontryck saenkande medel.
ES2171743T3 (es) Derivados de amidinas e isotioureas como inhibidores de la enzima sintasa de oxido nitrico.
ES2175437T3 (es) Composicion de enalapril y losartan.
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
NO923546L (no) Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde
NO923642L (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
NO990283L (no) Formulering for behandling og/eller profylakse av demens
SE8804317D0 (sv) Kompositioner foer reduktion av flebektasi jaemte foerfarande foer framstaellning av dessa
MD742C2 (ro) Remediu cu activitate regenerativă

Legal Events

Date Code Title Description
FD Application lapsed